Lawsuits Pile Up Alleging Remdesivir Killed COVID Patients

munkle

Diamond Member
Dec 18, 2012
4,561
7,516
1,930
Naturally anyone who got killed of the Remdesivir got marked down as COVID. The CDC stopped recommending R in later 2020, which shows they knew it was bad.

Lawsuits Pile Up Alleging Remdesivir Killed COVID Patients​


Despite research showing remdesivir is ineffective against COVID-19 and can cause high rates of organ failure, the U.S. Food and Drug Administration authorized the experimental antiviral drug for use against COVID-19

  • The antiviral drug remdesivir, brand name Veklury, is approved for use against COVID-19 despite research showing it lacks effectiveness and can cause high rates of organ failure.
  • John Beaudoin is calling for a criminal investigation into remdesivir, citing data that it may have killed 100,000 people in the U.S.
  • Beaudoin received all the death certificates in Massachusetts from 2015 to 2022, finding 1,840 excess deaths from acute renal failure from Jan. 1, 2021, to Nov. 30, 2022, which he believes may be due to remdesivir.
  • A study published in The Lancet found “no clinical benefit” from the use of remdesivir in hospitalized patients.
  • The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used.
The U.S. Food and Drug Administration (FDA) authorized the experimental antiviral drug remdesivir, brand name Veklury, for emergency use against COVID-19 in May 2020.

By October 2020, it had received full approval. It remains a primary treatment for COVID-19 in hospitals, despite research showing it lacks effectiveness and can cause high rates of organ failure.

On Twitter, John Beaudoin is calling for a criminal investigation into the drug, citing data that it may have killed 100,000 people in the U.S.

“They know,” he says, “or they willfully refuse to know. Either way, it’s homicide.”

Using drugs that cause organ failure, like remdesivir, isn’t in the best interest of public health. The fact that U.S. health authorities have focused on this and similarly harmful drugs to the exclusion of all others, including older drugs with high rates of effectiveness and superior safety profiles, sends a very disturbing message.

Did remdesivir kill thousands in Massachusetts?

Beaudoin has filed a lawsuit in U.S. District Court and believes a spike in deaths from acute renal failure (ARF) in Massachusetts is due to remdesivir, which is produced by Gilead Sciences.

Using a Freedom of Information Act (FOIA) request, Beaudoin received all the death certificates in Massachusetts from 2015 to 2022.

He then graphed the FOIA data, finding 1,840 excess deaths from acute renal failure from Jan. 1, 2021 to Nov. 30, 2022. Beaudoin also revealed an increase in deaths from acute rental failure in every age group over 15 years old, from 2015 to 2022.

“Thousands dead in Massachusetts ARF likely due to Remdesivir. This requires CRIMINAL investigation,” he tweeted.

1711839728659.png



 
Naturally anyone who got killed of the Remdesivir got marked down as COVID. The CDC stopped recommending R in later 2020, which shows they knew it was bad.

Lawsuits Pile Up Alleging Remdesivir Killed COVID Patients​


Despite research showing remdesivir is ineffective against COVID-19 and can cause high rates of organ failure, the U.S. Food and Drug Administration authorized the experimental antiviral drug for use against COVID-19

  • The antiviral drug remdesivir, brand name Veklury, is approved for use against COVID-19 despite research showing it lacks effectiveness and can cause high rates of organ failure.
  • John Beaudoin is calling for a criminal investigation into remdesivir, citing data that it may have killed 100,000 people in the U.S.
  • Beaudoin received all the death certificates in Massachusetts from 2015 to 2022, finding 1,840 excess deaths from acute renal failure from Jan. 1, 2021, to Nov. 30, 2022, which he believes may be due to remdesivir.
  • A study published in The Lancet found “no clinical benefit” from the use of remdesivir in hospitalized patients.
  • The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used.
The U.S. Food and Drug Administration (FDA) authorized the experimental antiviral drug remdesivir, brand name Veklury, for emergency use against COVID-19 in May 2020.

By October 2020, it had received full approval. It remains a primary treatment for COVID-19 in hospitals, despite research showing it lacks effectiveness and can cause high rates of organ failure.

On Twitter, John Beaudoin is calling for a criminal investigation into the drug, citing data that it may have killed 100,000 people in the U.S.

“They know,” he says, “or they willfully refuse to know. Either way, it’s homicide.”

Using drugs that cause organ failure, like remdesivir, isn’t in the best interest of public health. The fact that U.S. health authorities have focused on this and similarly harmful drugs to the exclusion of all others, including older drugs with high rates of effectiveness and superior safety profiles, sends a very disturbing message.

Did remdesivir kill thousands in Massachusetts?

Beaudoin has filed a lawsuit in U.S. District Court and believes a spike in deaths from acute renal failure (ARF) in Massachusetts is due to remdesivir, which is produced by Gilead Sciences.

Using a Freedom of Information Act (FOIA) request, Beaudoin received all the death certificates in Massachusetts from 2015 to 2022.

He then graphed the FOIA data, finding 1,840 excess deaths from acute renal failure from Jan. 1, 2021 to Nov. 30, 2022. Beaudoin also revealed an increase in deaths from acute rental failure in every age group over 15 years old, from 2015 to 2022.

“Thousands dead in Massachusetts ARF likely due to Remdesivir. This requires CRIMINAL investigation,” he tweeted.

View attachment 924755


Key words: "Beaudoin received all the death certificates in Massachusetts from 2015 to 2022."

2015 was five years before Covid. Remdesivir is used to treat a wide spectrum of illnesses. For example, Ebola, MERS, and SARS.

It is used as a last ditch defense when death is all but certain.

If remdesivir fails to save a life, that is not an "excess death" caused by remdesivir. That is a life that was going to perish regardless and could not be saved.

Remsdesivir has saved many lives.

Final report confirms remdesivir benefits for COVID-19



Researchers began a randomized, controlled trial of the antiviral in February 2020 to test whether remdesivir could be used to treat SARS-CoV-2, the coronavirus that causes COVID-19. By April, early results indicated that remdesivir accelerated recovery for hospitalized patients with severe COVID-19. It became the first drug to receive emergency use authorization from the U.S. Food and Drug Administration (FDA) to treat people hospitalized with COVID-19.



"Patients with severe Covid-19."

As I said, a last ditch effort when death is all but certain.

It's not a perfect drug. Just because it does not have a 100 percent success rate does not mean it kills people.

Think of chemo. Almost everyone has "adverse effects" from chemo. It destroys healthy cells and organs as well as tumors. Your hair falls out. And not everyone survives treatment.

Should we stop giving chemo to cancer victims? Of course not.

Until we find something better, we use what we have in our arsenal.
 
Last edited:
ANECDOTE!!! There's been an uptick in pneumonia of late blamed on Covid (according to a friend of mine who recently got the disease). She was told by her treating physician who assumed that, as several of her family members got Covid, so did she.) Sounds reasonable. I had Covid and got pneumonia over a year later. Quite a few who have had Covid also got pneumonia later locally. Good call.....or is it???

She never had Covid, though she did, like me, have the shots.

Greg
 
Key words: "Beaudoin received all the death certificates in Massachusetts from 2015 to 2022."

2015 was five years before Covid. Remdesivir is used to treat a wide spectrum of illnesses. For example, Ebola, MERS, and SARS.

It is used as a last ditch defense when death is all but certain.

If remdesivir fails to save a life, that is not an "excess death" caused by remdesivir. That is a life that was going to perish regardless and could not be saved.

Remsdesivir has saved many lives.

Final report confirms remdesivir benefits for COVID-19



Researchers began a randomized, controlled trial of the antiviral in February 2020 to test whether remdesivir could be used to treat SARS-CoV-2, the coronavirus that causes COVID-19. By April, early results indicated that remdesivir accelerated recovery for hospitalized patients with severe COVID-19. It became the first drug to receive emergency use authorization from the U.S. Food and Drug Administration (FDA) to treat people hospitalized with COVID-19.



"Patients with severe Covid-19."

As I said, a last ditch effort when death is all but certain.

It's not a perfect drug. Just because it does not have a 100 percent success rate does not mean it kills people.

Think of chemo. Almost everyone has "adverse effects" from chemo. It destroys healthy cells and organs as well as tumors. Your hair falls out. And not everyone survives treatment.

Should we stop giving chemo to cancer victims? Of course not.

Until we find something better, we use what we have in our arsenal.
But sadly, none of that feeds the manipulated paranoid conspiracy narrative, the intellectual foundation of MAGA.
 
Key words: "Beaudoin received all the death certificates in Massachusetts from 2015 to 2022."

2015 was five years before Covid. Remdesivir is used to treat a wide spectrum of illnesses. For example, Ebola, MERS, and SARS.

It is used as a last ditch defense when death is all but certain.

If remdesivir fails to save a life, that is not an "excess death" caused by remdesivir. That is a life that was going to perish regardless and could not be saved.

Remsdesivir has saved many lives.

Final report confirms remdesivir benefits for COVID-19



Researchers began a randomized, controlled trial of the antiviral in February 2020 to test whether remdesivir could be used to treat SARS-CoV-2, the coronavirus that causes COVID-19. By April, early results indicated that remdesivir accelerated recovery for hospitalized patients with severe COVID-19. It became the first drug to receive emergency use authorization from the U.S. Food and Drug Administration (FDA) to treat people hospitalized with COVID-19.



"Patients with severe Covid-19."

As I said, a last ditch effort when death is all but certain.

It's not a perfect drug. Just because it does not have a 100 percent success rate does not mean it kills people.

Think of chemo. Almost everyone has "adverse effects" from chemo. It destroys healthy cells and organs as well as tumors. Your hair falls out. And not everyone survives treatment.

Should we stop giving chemo to cancer victims? Of course not.

Until we find something better, we use what we have in our arsenal.

No it wasn't last ditch it was the first thing they did. Then the patient would slide downhill and they could finish him of by intubating him.
 

Forum List

Back
Top